Funded Tech Companies

SciRhom

Operating out of Martinsried, SciRhom raised its funding from Wellington Partners, Hadean Ventures and PhiFund Ventures.

Company Overview

Company Name
SciRhom
Company Status
Private & Independent
Industry
Life Sciences
Funding Rounds

Contact Information

Mailing Address
Am Klopferspitz 19
Martinsried, 82152
Germany
Email Address

Company Background Information

Overview
SciRhom GmbH is a pioneering biotech enterprise with the vision to translate advanced scientific findings into game-changing therapies for autoimmune diseases. Building on a detailed understanding of how a major cell-surface protease controls inflammation, SciRhom has worked closely with Prof. Carl Blobel of the Hospital for Special Surgery in New York City (USA) to develop first-in-class humanized antibodies against iRhom2.
Profile
SciRhom LinkedIn Company Profile
Social Media
SciRhom Company Twitter Account
Company News
SciRhom News
Facebook
SciRhom on Facebook
YouTube
SciRhom on YouTube
Last Transaction
7/9/2024

Financing History

Date
Type
Amount
Venture Equity
$68,000,000


Management Team

Title
Name
Email & Social
Chief Executive Officer
Jan Poth
  Jan Poth LinkedIn Profile  Jan Poth Twitter Account  Jan Poth News  Jan Poth on Facebook
Chief Executive Officer
Jens Ruhe
  Jens Ruhe LinkedIn Profile  Jens Ruhe Twitter Account  Jens Ruhe News  Jens Ruhe on Facebook
Chief Medical Officer
Jürgen Reeß
  Jürgen Reeß LinkedIn Profile  Jürgen Reeß Twitter Account  Jürgen Reeß News  Jürgen Reeß on Facebook
Chief Scientific Officer
Matthias Schneider
  Matthias Schneider LinkedIn Profile  Matthias Schneider Twitter Account  Matthias Schneider News  Matthias Schneider on Facebook


Company Investors

 

 

 

Browse more funded tech companies:

SciQuest | Scitara

 

Share this article

 


About Our VC Transaction Database

This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary